50629 Impact of Achieving F-VASI 75 or T-VASI 50 on Patient- and Physician-Reported Outcomes in Patients With Non-Segmental Vitiligo (NSV) Receiving Upadacitinib During a Phase 2 Study

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2024-09, Vol.91 (3), p.AB52-AB52
Main Authors: Rosmarin, David, Soliman, Ahmed M., Barqawi, Yazan K., Li, Chao, Schlosser, Bethanee J., Ezzedine, Khaled
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0190-9622
DOI:10.1016/j.jaad.2024.07.213